BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ISIS Services, LLC Announces Deb Kaldunski as Director of Client Services


5/26/2011 10:11:21 AM

San Carlos, CA, May 26, 2011 - ISIS Services, a leading preclinical and medical device contract research organization announced today that Deb Kaldunski has been appointed Director of Client Services. Kaldunski has extensive expertise in laboratory animal science and biomedical technology, including project management, operations, marketing and client communications. She will oversee ISIS’ sales and marketing strategies in the medical device and biotech fields, working with organizations which benefit from the utilization of ISIS’ scientific expertise and facilities.

“I’m excited about undertaking the role of Director of Client Services for ISIS. The organization has made great strides in its growth and development over the past 24 months and I’m thrilled to be able to connect with the clients that rely on our services to advance medical research,” said Kaldunski.

Kaldunski brings a breadth of experience to her new role at ISIS. Over the past decade, she has worked for a several organizations in a sales and marketing capacity where she represented research models and biomedical technology services to academic and biotech industries and the pharma arena. Deb also served as an Account Manager for Covance Research Products and oversaw the sales and management of peptide and antibody production for SynPep Corporation.

“We are pleased that Deb has joined our organization and is assuming leadership for a role that is key to the future growth of our company and our field. She brings a strong analytical background and her relationship management experience is unparalleled,” said Dr. Jorge Garcia, Chief Scientific Officer of ISIS Services. “We know Deb will strengthen the ISIS brand and vision in the coming years.”

Deb Kaldunski is on the Board of Directors for the California Society of Biomedical Research and is also a member of both the Northern California Branch of the American Association for Laboratory Animal Science (NCBAALAS) and the American Association for Laboratory Animal Science (AALAS). Deb received her Bachelor of Science from the University of California Berkeley in 1978. Kaldunski can be reached at 510-704-0140 or via e-mail at d.kaldunski@isis-services.com.

About ISIS Services

With over twenty-five years of experience in comparative medicine, ISIS Services has established a reputation for excellent science, strong surgical and clinical skills and customized, timely services. The company is the longest running, fully independent contract surgical facility in North America and has been conducting GLP studies since 1983. ISIS Services offers specialized services that support every step of your project goals—from prototype development and GLP clinical trials to surgeon training and market expansion studies. At each of these steps, ISIS Services provides expert capabilities in comparative medicine, surgery and pathology to help optimize device design and performance. Our pre-clinical GLP and non-GLP capabilities range from feasibility studies, to safety and efficacy assessments, to physician and sales force training. The scope and nature of these studies include: cardiovascular, orthopedic, gastrointestinal, urogenital, dermatological, and wound healing-- with an emphasis on medical device development and biomaterial testing. www.ISIS-Services.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES